KOPRAN
|
The Current P/B Ratio of KOPRAN is 1.49.
Share Price | ₹159.0 | Aug 22,2025 |
Market Cap | ₹768.0 Cr | |
Book Value | ₹516.7 Cr | Mar2025 - Consolidated Results |
Price/Book | 1.49x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of KOPRAN
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹768.0 Cr] as on Aug 22,2025
(/) Book Value [ ₹516.7 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 1.49x ]
Thus, for KOPRAN , the investors are currently willing to pay '1.49 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of KOPRAN !
The chart below summarizes the trend in P/B Ratio of KOPRAN over the last five years.
Historical PB (Price/Book ) ratio chart of KOPRAN
PB Ratio Performance Analysis for KOPRAN
- KOPRAN 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.09x.
- KOPRAN 's operated at median p/b ratio of 1.85x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KOPRAN 's p/b ratio peaked in Mar2022 at 3.19x.
- KOPRAN 's p/b ratio hit its five-year low in Mar2023 of 1.21x.
How does KOPRAN 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
KOPRAN | 516.73 | 1.49 | 768.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.46 | 394,187.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 10.91 | 163,282.0 |
CIPLA LTD | 31,079.30 | 4.14 | 128,619.0 |
TORRENT PHARMACEUTICALS LTD | 7,590.69 | 16.43 | 124,712.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.19 | 106,577.0 |
MANKIND PHARMA LTD | 14,288.70 | 7.53 | 107,559.0 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.15 | 99,496.4 |
LUPIN LTD | 17,119.50 | 5.27 | 90,234.1 |
AUROBINDO PHARMA LTD | 32,653.30 | 1.87 | 60,998.7 |
ABBOTT INDIA LTD | 4,204.27 | 16.13 | 67,806.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs KOPRAN 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 1.49x |
Max industry PB | 16.43x |
Median industry PB | 5.27x |
Average industry PB | 6.96x |
You may also like the below Video Courses